GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dannex Ayrton Starwin PLC (XGHA:DASPHARMA) » Definitions » Non Operating Income

Dannex Ayrton Starwin (XGHA:DASPHARMA) Non Operating Income : GHS Mil (TTM As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Dannex Ayrton Starwin Non Operating Income?

Non Operating Income is income or expense that comes from miscellaneous sources. Dannex Ayrton Starwin's Non Operating Income for the six months ended in . 20 was GHS0.00 Mil.


Dannex Ayrton Starwin Non Operating Income Historical Data

The historical data trend for Dannex Ayrton Starwin's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dannex Ayrton Starwin Non Operating Income Chart

Dannex Ayrton Starwin Annual Data
Trend
Non Operating Income

Dannex Ayrton Starwin Semi-Annual Data
Non Operating Income

Dannex Ayrton Starwin Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.


Dannex Ayrton Starwin Non Operating Income Related Terms

Thank you for viewing the detailed overview of Dannex Ayrton Starwin's Non Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Dannex Ayrton Starwin (XGHA:DASPHARMA) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 5 Dadeban Road, Ring Road North, North Industrial Area, Accra, GHA
Dannex Ayrton Starwin PLC is a pharmaceutical company. The company offers a product range that includes tablets, capsules, liquids syrups and suspensions, powders, ointments, and chemicals. It also manufactures and distributes Vitamin C.

Dannex Ayrton Starwin (XGHA:DASPHARMA) Headlines

No Headlines